Linden Thomas Advisory Services LLC Purchases 3,837 Shares of FONAR Co. (NASDAQ:FONR)

Linden Thomas Advisory Services LLC boosted its position in FONAR Co. (NASDAQ:FONR) by 15.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 29,236 shares of the medical equipment provider’s stock after purchasing an additional 3,837 shares during the period. Linden Thomas Advisory Services LLC owned approximately 0.46% of FONAR worth $443,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its stake in FONAR by 148.3% in the third quarter. JPMorgan Chase & Co. now owns 3,012 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 1,799 shares during the last quarter. Corsair Capital Management L.P. increased its position in shares of FONAR by 8.8% during the third quarter. Corsair Capital Management L.P. now owns 27,972 shares of the medical equipment provider’s stock worth $453,000 after acquiring an additional 2,266 shares during the period. Empowered Funds LLC increased its position in shares of FONAR by 5.3% during the third quarter. Empowered Funds LLC now owns 18,690 shares of the medical equipment provider’s stock worth $303,000 after acquiring an additional 938 shares during the period. Inspire Advisors LLC increased its position in shares of FONAR by 21.2% during the third quarter. Inspire Advisors LLC now owns 34,342 shares of the medical equipment provider’s stock worth $556,000 after acquiring an additional 5,998 shares during the period. Finally, Lakewood Asset Management LLC purchased a new position in shares of FONAR during the third quarter worth approximately $173,000. Institutional investors own 50.64% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of FONAR from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 16th.

FONAR Stock Performance

Shares of NASDAQ:FONR opened at $16.00 on Monday. The firm has a market cap of $101.28 million, a PE ratio of 11.43 and a beta of 1.22. The firm’s 50 day simple moving average is $15.49 and its 200-day simple moving average is $16.21. FONAR Co. has a one year low of $14.05 and a one year high of $24.05.

FONAR (NASDAQ:FONR) last issued its quarterly earnings data on Tuesday, November 12th. The medical equipment provider reported $0.46 earnings per share (EPS) for the quarter. The company had revenue of $24.96 million for the quarter. FONAR had a net margin of 9.41% and a return on equity of 6.10%.

FONAR Company Profile

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.